Corium is headquartered in Menlo Park, CA, with manufacturing facilities in Grand Rapids, MI. StrataGent will relocate to the Corium Menlo Park headquarters.
About Corium International, Inc.
Corium International, Inc. is a privately-owned company engaged in the research, development and manufacture of advanced transdermal drug delivery technologies and products. Using its proprietary delivery technologies and its development and manufacturing expertise, Corium has developed a number of active and passive transdermal products with enhanced therapeutic or safety profiles. This self-funded product pipeline spans several therapeutic areas and is in various stages of development. Corium also has several
partner-funded products with small, medium and large pharmaceutical companies in various stages of development, ranging from manufacturing to research and development. Please visit http://www.coriumgroup.com
About StrataGent Life Sciences, Inc.
StrataGent Life Sciences, Inc. is a specialty drug delivery company
developing products for painless, needle-free administration of otherwise
injectable drugs. Its products are based on its proprietary microjet
technology that delivers large and small therapeutic molecules without a
device penetrating into or through the skin. In May of 2004, StrataGent
received a $2 million award from the Advanced Technology Program (ATP) at
the National Institute of Standards and Technology to support the
development of the StrataGent microjet technology. Earlier this year,
StrataGent announced a $16M Series B financing led
|SOURCE Corium International, Inc.|
Copyright©2007 PR Newswire.
All rights reserved